
Scott R. Kastler
Examiner (ID: 3419, Phone: (571)272-1243 , Office: P/1733 )
| Most Active Art Unit | 1733 |
| Art Unit(s) | 1793, 1101, 1733, 1742, 1311, 2899, 1308 |
| Total Applications | 4528 |
| Issued Applications | 3615 |
| Pending Applications | 164 |
| Abandoned Applications | 754 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20656623
[patent_doc_number] => 20260108657
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2026-04-23
[patent_title] => PHARMACEUTICAL COMPOSITIONS FOR TREATING OSTEOARTHRITIS
[patent_app_type] => utility
[patent_app_number] => 19/412669
[patent_app_country] => US
[patent_app_date] => 2025-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1080
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19412669
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/412669 | PHARMACEUTICAL COMPOSITIONS FOR TREATING OSTEOARTHRITIS | Dec 7, 2025 | Issued |
Array
(
[id] => 20458175
[patent_doc_number] => 20260007595
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2026-01-08
[patent_title] => EYE DROP FORMULATIONS CONTAINING CHONDROITIN SULFATE FOR RELIEVING OCULAR PAIN OR DISCOMFORT
[patent_app_type] => utility
[patent_app_number] => 19/329207
[patent_app_country] => US
[patent_app_date] => 2025-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3612
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19329207
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/329207 | EYE DROP FORMULATIONS CONTAINING CHONDROITIN SULFATE FOR RELIEVING OCULAR PAIN OR DISCOMFORT | Sep 14, 2025 | Pending |
Array
(
[id] => 20401329
[patent_doc_number] => 12491289
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-09
[patent_title] => Pharmaceutical compositions for treating osteoarthritis
[patent_app_type] => utility
[patent_app_number] => 19/186434
[patent_app_country] => US
[patent_app_date] => 2025-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 12
[patent_no_of_words] => 1080
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19186434
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/186434 | Pharmaceutical compositions for treating osteoarthritis | Apr 21, 2025 | Issued |
Array
(
[id] => 20401244
[patent_doc_number] => 12491204
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-09
[patent_title] => Use of oleanolic acid-28-O-beta-D-glucopyranoside in preparation of anti-colitis drug
[patent_app_type] => utility
[patent_app_number] => 18/978008
[patent_app_country] => US
[patent_app_date] => 2024-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 19
[patent_no_of_words] => 0
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18978008
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/978008 | Use of oleanolic acid-28-O-beta-D-glucopyranoside in preparation of anti-colitis drug | Dec 11, 2024 | Issued |
Array
(
[id] => 19831036
[patent_doc_number] => 20250082822
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-03-13
[patent_title] => PHARMACEUTICAL COMPOSITIONS FOR TREATING OSTEOARTHRITIS
[patent_app_type] => utility
[patent_app_number] => 18/960884
[patent_app_country] => US
[patent_app_date] => 2024-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5989
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18960884
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/960884 | Pharmaceutical compositions for treating osteoarthritis | Nov 25, 2024 | Issued |
Array
(
[id] => 19599621
[patent_doc_number] => 20240390501
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-28
[patent_title] => COLON-TARGETED ACTIVE AGENT DELIVERY CARRIER AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/792077
[patent_app_country] => US
[patent_app_date] => 2024-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9687
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 188
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18792077
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/792077 | Colon-targeted active agent delivery carrier and uses thereof | Jul 31, 2024 | Issued |
Array
(
[id] => 19541694
[patent_doc_number] => 20240358730
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-31
[patent_title] => PREBIOTIC COMPOSITIONS AND METHODS OF PRODUCTION THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/765449
[patent_app_country] => US
[patent_app_date] => 2024-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4778
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18765449
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/765449 | PREBIOTIC COMPOSITIONS AND METHODS OF PRODUCTION THEREOF | Jul 7, 2024 | Abandoned |
Array
(
[id] => 19477379
[patent_doc_number] => 20240325421
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-03
[patent_title] => PTEN INHIBITORS FOR TREATMENT AND PREVENTION OF BONE MARROW LOSS
[patent_app_type] => utility
[patent_app_number] => 18/740196
[patent_app_country] => US
[patent_app_date] => 2024-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12457
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18740196
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/740196 | PTEN INHIBITORS FOR TREATMENT AND PREVENTION OF BONE MARROW LOSS | Jun 10, 2024 | Pending |
Array
(
[id] => 19462425
[patent_doc_number] => 20240316094
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-26
[patent_title] => AEROSOL AND TOPICAL ADMINISTRATION OF A FORMULATION CONTAINING CYCLODEXTRIN, QUERCETIN AND ZINC, IN COMBINATION OR SEPARATELY, TO MITIGATE INFECTION BY ENVELOPED VIRUSES
[patent_app_type] => utility
[patent_app_number] => 18/680557
[patent_app_country] => US
[patent_app_date] => 2024-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2054
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18680557
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/680557 | AEROSOL AND TOPICAL ADMINISTRATION OF A FORMULATION CONTAINING CYCLODEXTRIN, QUERCETIN AND ZINC, IN COMBINATION OR SEPARATELY, TO MITIGATE INFECTION BY ENVELOPED VIRUSES | May 30, 2024 | Pending |
Array
(
[id] => 20270746
[patent_doc_number] => 12440510
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-10-14
[patent_title] => Use of chondroitin sulfate for relieving ocular pain
[patent_app_type] => utility
[patent_app_number] => 18/654457
[patent_app_country] => US
[patent_app_date] => 2024-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 0
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18654457
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/654457 | Use of chondroitin sulfate for relieving ocular pain | May 2, 2024 | Issued |
Array
(
[id] => 20437421
[patent_doc_number] => 12508242
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-30
[patent_title] => Compositions and methods for treatment of diabetic neuropathies
[patent_app_type] => utility
[patent_app_number] => 18/641536
[patent_app_country] => US
[patent_app_date] => 2024-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 779
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18641536
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/641536 | Compositions and methods for treatment of diabetic neuropathies | Apr 21, 2024 | Issued |
Array
(
[id] => 19512067
[patent_doc_number] => 20240343753
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-17
[patent_title] => THERAPEUTIC COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 18/633908
[patent_app_country] => US
[patent_app_date] => 2024-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9478
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18633908
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/633908 | THERAPEUTIC COMPOUNDS | Apr 11, 2024 | Pending |
Array
(
[id] => 19808292
[patent_doc_number] => 12239651
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-03-04
[patent_title] => Treatment of hearing loss
[patent_app_type] => utility
[patent_app_number] => 18/609604
[patent_app_country] => US
[patent_app_date] => 2024-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 25309
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18609604
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/609604 | Treatment of hearing loss | Mar 18, 2024 | Issued |
Array
(
[id] => 19232151
[patent_doc_number] => 20240189342
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-13
[patent_title] => OPHTHALMIC SOLUTIONS
[patent_app_type] => utility
[patent_app_number] => 18/584219
[patent_app_country] => US
[patent_app_date] => 2024-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4003
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18584219
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/584219 | OPHTHALMIC SOLUTIONS | Feb 21, 2024 | Abandoned |
Array
(
[id] => 19641340
[patent_doc_number] => 20240415860
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-19
[patent_title] => FORMULATIONS AND METHODS FOR TREATING CONDITIONS OF THE EYE
[patent_app_type] => utility
[patent_app_number] => 18/430551
[patent_app_country] => US
[patent_app_date] => 2024-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21298
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18430551
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/430551 | FORMULATIONS AND METHODS FOR TREATING CONDITIONS OF THE EYE | Jan 31, 2024 | Pending |
Array
(
[id] => 19187969
[patent_doc_number] => 20240166882
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-23
[patent_title] => COLOUR-STABLE PREPARATION OF A MAGNESIUM CHLOROPHYLLIN ALKALI METAL SALT OR ALKALI EARTH METAL SALT FROM NATURAL SOURCES OF CHLOROPHYLL
[patent_app_type] => utility
[patent_app_number] => 18/423614
[patent_app_country] => US
[patent_app_date] => 2024-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16841
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18423614
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/423614 | COLOUR-STABLE PREPARATION OF A MAGNESIUM CHLOROPHYLLIN ALKALI METAL SALT OR ALKALI EARTH METAL SALT FROM NATURAL SOURCES OF CHLOROPHYLL | Jan 25, 2024 | Pending |
Array
(
[id] => 19343752
[patent_doc_number] => 20240252715
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-01
[patent_title] => PHARMACEUTICAL COMPOSITIONS FOR TREATING OSTEOARTHRITIS
[patent_app_type] => utility
[patent_app_number] => 18/424626
[patent_app_country] => US
[patent_app_date] => 2024-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5974
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18424626
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/424626 | Pharmaceutical compositions for treating osteoarthritis | Jan 25, 2024 | Issued |
Array
(
[id] => 19417314
[patent_doc_number] => 20240293437
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-05
[patent_title] => METHODS OF SELECTIVELY MODULATING GASTROINTESTINAL MICROBIAL GROWTH
[patent_app_type] => utility
[patent_app_number] => 18/420540
[patent_app_country] => US
[patent_app_date] => 2024-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 98868
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 150
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18420540
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/420540 | Methods of selectively modulating gastrointestinal microbial growth | Jan 22, 2024 | Issued |
Array
(
[id] => 19666182
[patent_doc_number] => 12178903
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2024-12-31
[patent_title] => Liquid composition comprising glucose
[patent_app_type] => utility
[patent_app_number] => 18/417312
[patent_app_country] => US
[patent_app_date] => 2024-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8702
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18417312
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/417312 | Liquid composition comprising glucose | Jan 18, 2024 | Issued |
Array
(
[id] => 19372908
[patent_doc_number] => 12064447
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2024-08-20
[patent_title] => None
[patent_app_type] => utility
[patent_app_number] => 18/399599
[patent_app_country] => US
[patent_app_date] => 2023-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 7669
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 152
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18399599
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/399599 | None | Dec 27, 2023 | Issued |